As of the latest Form 4 filed Jun 18, 2026.
What BCB Bancorp Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 15 most recent filings for BCBP.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | 2026-06-03 | Blake Ryan CHIEF OPERATING OFFICER | II | −5.84K | $11.11 | $64.9K | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Werdann Gerald Director | PPurchase | +4.40K | $11.28 | $49.6K | No | Form 4 ↗ |
| 2026-04-24 | 2026-04-22 | Werdann Gerald Director | AAward | +4.23K | $9.86 | $41.7K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | HOGAN MARK D Director | PPurchase | +5.00K | $7.97 | $39.9K | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | DiDomenico Vincent Jr Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | BIELAN JUDITH Q Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Rizzo James G. Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | LYGA JOSEPH Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Pulomena John Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | HOGAN MARK D Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | French Tara L Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Widmer Michael J Director | PPurchase | +2.00K | $8.40 | $16.8K | No | Form 4 ↗ |
| 2026-02-12 | 2026-02-10 | Widmer Michael J, Director | AAward | +5.95K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Garcia David Roque Chief Lending Officer | PPurchase | +1.70K | $9.59 | $16.3K | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | HOGAN MARK D Director | PPurchase | +1.20K | $9.68 | $11.6K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BCBP’s full analysis or the market-wide insider trading feed. The tabs above jump to BCBP’s other SEC data.
Source: SEC Form 4 filings for BCBP, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.